AI assistant
Charmacy Pharmaceutical Co., Ltd. — Board/Management Information 2017
Jun 11, 2017
50500_rns_2017-06-11_8de0e47e-695c-4ff0-b0c6-96cb56741c1c.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [66 x 55] intentionally omitted <==
CHARMACY PHARMACEUTICAL CO., LTD. 創美藥業股份有限公司
(a joint stock limited liability company established in the People’s Republic of China)
List of directors and their roles and functions
Members of the board of directors (the “ Board ”) of Charmacy Pharmaceutical Co., Ltd. are set out below:
-
Mr. Yao Chuanglong (Chairman, Executive Director and Chief Executive Officer)
-
Ms. Zheng Yuyan (Vice President, Executive Director and Chief Marketing Officer)
-
Mr. Fan Jianbo (Vice President, Executive Director and Chief Technical Officer)
-
Mr. Lin Zhixiong (Executive Director, Joint Company Secretary and Chief Financial Officer)
-
Ms. You Zeyan (Non-executive Director)
-
Mr. Li Weisheng (Non-executive Director)
-
Mr. Wan Chi Wai Anthony (Independent Non-executive Director)
-
Mr. Zhou Tao (Independent Non-executive Director)
-
Mr. Guan Jian (also known as Guan Suzhe) (Independent Non-executive Director)
The Board has established the Audit Committee, the Nomination Committee, the Remuneration Committee, the Strategic Development Committee and the Risk Management Committee and these committees are comprised of the following members:
| Committee | Members |
|---|---|
| Audit Committee | Mr. Wan Chi Wai Anthony_(Chairman)_ |
| Mr. Zhou Tao_(Member)_ | |
| Mr. Guan Jian_(Member)_ | |
| Nomination Committee | Mr. Zhou Tao_(Chairman)_ |
| Mr. Yao Chuanglong_(Member)_ | |
| Mr. Guan Jian_(Member)_ | |
| Remuneration Committee | Mr. Zhou Tao_(Chairman)_ |
| Mr. Wan Chi Wai Anthony_(Member)_ | |
| Ms. You Zeyan_(Member)_ | |
| Strategic Development Committee | Mr. Yao Chuanglong_(Chairman)_ |
| Ms. Zheng Yuyan_(Member)_ | |
| Mr. Zhou Tao_(Member)_ | |
| Risk Management Committee | Mr. Yao Chuanglong_(Chairman)_ |
| Mr. Lin Zhixiong_(Member)_ | |
| Mr. Wan Chi Wai Anthony_(Member)_ | |
| Hong Kong, 10 June 2017 |